The test analyzes the levels of two proteins in the blood and has shown a link between these levels and patient outcomes. The pilot study showed that 98% of patients with low protein levels did not develop secondary breast cancer. The test could be ready for approval in two to three years.
Latest News
22:58
The Oradea City Hall will turn on the public lighting an hour later to reduce energy consumption.
22:42
Volodymyr Zelensky dismissed Olha Stefanișena from the position of ambassador to the USA, in the context of allegations of embezzlement.
22:30
Switzerland: An outbreak of legionellosis in Basel has led to 26 cases / Authorities suspect cooling towers as the source of contamination
22:18
Unit 2 of the Cernavodă Nuclear Power Plant can operate for only five days due to the decrease in the Danube's water level.
21:57
At Mița, the cyclist turns off the architectural lighting of the facade to reduce energy consumption.
See more news